To the Editor: The discussion regarding increased currency and updating of prescription drug information (product information, PI)1 provides on opportunity for insightful and valuable debate. MIMS (a compilation of PI)2 supports any initiatives that result in PI and consumer medicine information (CMI) being updated more regularly, and I would like to clarify MIMS’ specific role in the process.
The full article is accessible to AMA
members and paid subscribers.
Login to MJA or subscribe now.
- MIMS, Sydney, NSW.
Correspondence: elizabeth.donohoo@mims.com.au
- 1. Stockigt JR. Barriers in the quest for quality drug information: salutary lessons from TGA-approved sources for thyroid-related medications. Med J Aust 2007; 186: 76-79. <MJA full text>
- 2. MIMS annual. 30th ed. Sydney: CMPMedica Australia, 2006.
- 3. Dowden JS. Product information past perfect [editorial]. Med J Aust 2007; 186: 51-52. <MJA full text>
Online responses are no longer available. Please refer to our instructions for authors page for more information.